Yongbing Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 18
- Advanced biosensing and bioanalysis techniques 12
- Oncology 32
- Cancer Immunotherapy and Biomarkers 10
- Cancer Cells and Metastasis 7
- Co-authors
- Lichen Yin (28 shared papers)Rongying Zhu (28 shared papers)Shanzhou Duan (33 shared papers)Donglai Chen (49 shared papers)Huan Ye (5 shared papers)Ziyin Zhao (9 shared papers)Mingjing Shen (11 shared papers)Xuejie Wu (8 shared papers)
- Journals
- Biomaterials Science (6 papers)Lung Cancer (6 papers)Oncotarget (5 papers)European Journal of Cardio-Thoracic Surgery (4 papers)Annals of Translational Medicine (3 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Yongbing Chen
164 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 459
- Biomaterials 429
- Pulmonary and Respiratory Medicine 648
- Oncology 548
- Molecular Biology 1.3k
Countries citing papers authored by Yongbing Chen
This map shows the geographic impact of Yongbing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbing Chen more than expected).
Fields of papers citing papers by Yongbing Chen
This network shows the impact of papers produced by Yongbing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbing Chen. The network helps show where Yongbing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongbing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 219 | |
| 2 | 2019 | 165 | |
| 3 | 2018 | 119 | |
| 4 | 2018 | 104 | |
| 5 | 2023 | 93 | |
| 6 | 2021 | 87 | |
| 7 | 2017 | 85 | |
| 8 | 2018 | 84 | |
| 9 | 2015 | 84 | |
| 10 | 2021 | 81 | |
| 11 | 2022 | 66 | |
| 12 | 2022 | 65 | |
| 13 | 2019 | 65 | |
| 14 | 2017 | 62 | |
| 15 | 2015 | 61 | |
| 16 | 2019 | 59 | |
| 17 | 2017 | 52 | |
| 18 | 2021 | 52 | |
| 19 | 2016 | 51 | |
| 20 | 2016 | 51 |
About Yongbing Chen
Yongbing Chen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 180 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (19 papers), RNA Interference and Gene Delivery (18 papers), Esophageal Cancer Research and Treatment (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Nanoplatforms for cancer theranostics (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), MicroRNA in disease regulation (9 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (459 citations), Biomaterials (429 citations), Pulmonary and Respiratory Medicine (648 citations), Oncology (548 citations) and Molecular Biology (1.3k citations). Yongbing Chen has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Lichen Yin, Rongying Zhu, Shanzhou Duan, Donglai Chen, Huan Ye, Ziyin Zhao, Mingjing Shen, Xuejie Wu, Hua He and Yong Liu. Their work appears in journals such as Biomaterials Science, Lung Cancer, Oncotarget, European Journal of Cardio-Thoracic Surgery and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.